Key Ingredients
Mirabegron (50 mg – Extended Release): Formulated using a controlled-release matrix that ensures slow, uniform absorption over 24 hours. This maintains consistent β3-agonist activity, stabilizing bladder function and reducing sudden involuntary urges.
Benefits
Advanced Extended Release Technology: The ER system delivers Mirabegron steadily, avoiding peak-related side effects and ensuring constant therapeutic levels in the body.
Once-Daily Compliance: Sustained-release formulation simplifies dosing and improves patient adherence in long-term OAB therapy.
Consistent Bladder Relaxation: Enhanced storage capacity due to prolonged β3-receptor stimulation.
Superior Symptom Control: Significant reduction in urgency, daytime frequency, nighttime urination, and urge incontinence episodes.
Minimized Systemic Side Effects: Stable plasma concentration reduces chances of hypertension spikes or tachycardia associated with immediate-release forms.
Usage Instructions
- Take one MIRADEY-50 ER tablet daily as directed by your physician.
- Swallow whole; do not split, crush, or chew to preserve the ER mechanism.
- Regular use ensures maximum therapeutic benefit.
Side Effects
Patients may experience headache, mild hypertension, dry mouth, constipation, or bladder discomfort.
Seek medical advice if symptoms persist or worsen.
General Information
- Strength: Mirabegron 50 mg (Extended Release)
- Form: Tablet, ER
- Brand: MIRADEY-50
- Packaging Size: 10×10 Tablets
- Packaging Type: Box / Strip
- Manufacturer: Globus Labs
- Deals In: PCD Pharma
- Shelf Life: Standard pharmaceutical stability
- Country of Origin: India
Globus Labs brings you WHO-GMP–certified, high-quality Mirabegron 50 mg sourced from reputed pharmaceutical manufacturers. MIRADEY-50 is formulated to deliver safe, potent, and clinically trusted support.
